Supplementary
Cell Bank in SCGM tissue culture medium.
Supplementary Figure 1. Expression of KIR molecules by NKAES NK cells. (A)
Peripheral blood mononuclear cells from 1 healthy donor (representative of 3) were placed in NKAES cultures for 18 days. T cell depletion was performed on day 7. The expression of KIR molecules was assessed on CD56 + CD3 -cells before culture and after 18 days of culture. Percentages of NK cell subsets expressing different KIR molecules are shown in the flow cytometric dot plots. (B) NK cells from 6 healthy donors were placed in NKAES cultures for 7 days. Expansion of CD56 + CD3 -expressing KIR2DL1, KIR2DL2/3 and/or KIR3DL1 ("KIR + ") and those lacking these molecules ("KIR -") is shown as fold cell recovery of input cells.
Supplementary Figure 2 . Antileukemic activity of NKAES NK cells derived from acute leukemia patients against AML cell lines. NKAES NK cells were derived from the peripheral blood of 3 patients with acute leukemia in clinical remission. Cytotoxicity against leukemic cell lines was tested at the indicated E :T for 4 hours. The mean of four measurements is shown at each E : T ratio. Gray areas correspond to the range of cytotoxicities obtained with NKAES NK cells derived from healthy donors against the same cell lines (see Fig. 4 ).
